Dmitry Balyasny’s Mustang Bio MBIO Stock Holding History

Dmitry Balyasny’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-42	Closed	-$15K	–	3039
2022 Q3	$15K	Buy	42 +24	+133%	+$11.1K	﹤0.01%	2606
2022 Q2	$8K	Buy	+18	New	+$9.96K	﹤0.01%	2605

Other funds holding MBIO

AWA

Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Dmitry Balyasny's MBIO Position: Q4 2022 in Review

Dmitry Balyasny sold out of Mustang Bio (MBIO) in Q4 2022, closing a stake of 42 shares — an estimated $15K sold.

Dmitry Balyasny first reported a position in MBIO in Q2 2022 and held it in 2 quarters. The position peaked at $15K in Q3 2022. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

Dmitry Balyasny reported no remaining Mustang Bio position as of Q4 2022 after selling out during the quarter.
Dmitry Balyasny sold 42 Mustang Bio shares in Q4 2022, an estimated $15K.
Dmitry Balyasny first reported a position in Mustang Bio in Q2 2022 and held it in 2 quarters.
Dmitry Balyasny's Mustang Bio position peaked at $15K in Q3 2022.
60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.